Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Clemons M, Stober C, Pond GR, Conter H, Simos D, Dhesy-Thind S, Mates M, Trinkaus M, Hilton J, Savard MF, Fergusson D, Vandermeer L, Awan AA

Open source

DOI: 10.1056/evidoa2500202
Published: 2026 Jun
Container: NEJM evidence
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2500202,
  title = {Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.},
  author = {Clemons M and Stober C and Pond GR and Conter H and Simos D and Dhesy-Thind S and Mates M and Trinkaus M and Hilton J and Savard MF and Fergusson D and Vandermeer L and Awan AA},
  year = {2026},
  journal = {NEJM evidence},
  doi = {10.1056/evidoa2500202},
  url = {https://doi.org/10.1056/evidoa2500202}
}

RIS

TY  - JOUR
TI  - Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.
AU  - Clemons M
AU  - Stober C
AU  - Pond GR
AU  - Conter H
AU  - Simos D
AU  - Dhesy-Thind S
AU  - Mates M
AU  - Trinkaus M
AU  - Hilton J
AU  - Savard MF
AU  - Fergusson D
AU  - Vandermeer L
AU  - Awan AA
PY  - 2026
JO  - NEJM evidence
DO  - 10.1056/evidoa2500202
UR  - https://doi.org/10.1056/evidoa2500202
ER  -

APA

M, C., C, S., GR, P., H, C., D, S., S, D., M, M., M, T., J, H., MF, S., D, F., L, V., & AA, A. (2026). Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.. NEJM evidence. https://doi.org/10.1056/evidoa2500202

Source records

pubmed · retrieved 2026-09-26T16:09:23.524Z